B. Braun Medical Inc. (B. Braun) announced today the availability of large volume heparin infusion solutions. Based on the new United States Pharmacopeia (USP) standards for heparin products released ...
This was a single-center, observational cohort study conducted at an 852-bed academic medical center. The study involved a review of electronic and paper medical records of patients who received ...
January 19, 2011 (San Diego, California) — Subcutaneously administered heparin might not provide optimal protection against venous thromboembolism (VTE) for patients who have undergone major abdominal ...
Please provide your email address to receive an email when new articles are posted on . Patients with an allergic inflammatory skin reaction to subcutaneous heparin generally tolerated IV ...
RADNOR, Pa.--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular ...
Correctly diagnosing heparin resistance in patients on extracorporeal membrane oxygenation (ECMO) is challenging. In patients with sepsis, the differential diagnosis for heparin resistance is large, ...
Overview: Heparin is a blood thinner that is used to prevent or treat blood clots. It may be injected under the skin or into a blood vessel. The most common side effects are irritation at the ...
A pooled analysis of individual patient data from the major bivalirudin versus unfractionated heparin trials concludes that preprocedural bivalirudin could be considered the agent of choice in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results